An estimate of primary and secondary care resource utilisation per patient will be made using patient questionnaires and review of hospital notes over the first year after hospital discharge.
Despite these caveats and limitations, several advances in our understanding of neurological disorders have already been made using patient-derived hiPSCs (Brennand et al., 2012; Durak and Tsai, 2014; Gaspard and Vanderhaeghen, 2011).
Calculations were made using each patient.
The corresponding measures of active ROM (A. ABD/A. FLE/A. EXT/A. INT) were made using similar patient starting positions as for the passive movements.
This should not detract from the utility of the estimation procedure since the predicted medians were compared with additional data five years after the prediction was made using only those patients who were selected in the original study sample.
The validity of the estimations made using this approach for patients on PD is therefore questionable.
As the questionnaire scores for the cough patients were normally distributed, comparisons between treated cough and idiopathic patients were made using unpaired t-Tests.
Cerezyme is the enzyme that Gaucher patients lack, made using genetic engineering.
Comparisons between HIV-positive and HIV-negative patients were made using a Mann-Whitney U-test.
These results are in accordance to observations made using leukaemic cells from CML patients.
